| Langerhans Cell Histiocytosis studied in …STUDIED_INderived27 of 27show fewer |
|---|
| → studied in | NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 27 trials mapped (14 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03698994Phase 2 · active not recruiting Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 27 trials mapped (14 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02402244recruiting Project: Every Child for Younger Patients With Cancer · condition mapped ONTOLOGY_EXACT · 27 trials mapped (14 active) | — | — | Childhood Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07440290Phase 2/Phase 3 · recruiting DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. · condition mapped ONTOLOGY_EXACT · 27 trials mapped (14 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05028621NA · suspended Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease · condition mapped ONTOLOGY_EXACT · 27 trials mapped (14 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04320888Phase 2 · active not recruiting Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 27 trials mapped (14 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03155620Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 27 trials mapped (14 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02523040Phase 2 · active not recruiting Lenalidomide for Adult Histiocyte Disorders · condition mapped ONTOLOGY_EXACT · 27 trials mapped (14 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04284774Phase 2 · active not recruiting Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 27 trials mapped (14 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213652Phase 2 · active not recruiting Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 27 trials mapped (14 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195555Phase 2 · active not recruiting Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 27 trials mapped (14 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213704Phase 2 · active not recruiting Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 27 trials mapped (14 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05915208recruiting Histiocytic Disorder Follow-up Study · condition mapped ONTOLOGY_EXACT · 27 trials mapped (14 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213678Phase 2 · completed Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 27 trials mapped (14 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213665Phase 2 · completed Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 27 trials mapped (14 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03526250Phase 2 · completed Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 27 trials mapped (14 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06712810Phase 1 · recruiting Q702 for the Treatment of Patients With Hematologic Malignancies · condition mapped CURATED_BROADER · 27 trials mapped (14 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04079179Phase 2 · recruiting Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders · condition mapped ONTOLOGY_EXACT · 27 trials mapped (14 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03220035Phase 2 · completed Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 27 trials mapped (14 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03233204Phase 2 · completed Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 27 trials mapped (14 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03096782Phase 2 · completed Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma · condition mapped ONTOLOGY_EXACT · 27 trials mapped (14 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01273766Phase 2 · completed Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 27 trials mapped (14 active) | — | — | Adult Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002947Phase 1 · terminated Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer · condition mapped ONTOLOGY_EXACT · 27 trials mapped (14 active) | — | — | Childhood Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00008216terminated Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 27 trials mapped (14 active) | — | — | Adult Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890747Phase 1 · completed Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy · condition mapped ONTOLOGY_EXACT · 27 trials mapped (14 active) | — | — | Adult Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00084695Phase 2 · unknown Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases · condition mapped ONTOLOGY_EXACT · 27 trials mapped (14 active) | — | — | Childhood Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00008164Phase 2 · unknown Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia · condition mapped ONTOLOGY_EXACT · 27 trials mapped (14 active) | — | — | Childhood Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |